Skip to content

Clinical trials

Withdrawn Idiopathic Pulmonary Fibrosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Idiopathic Pulmonary Fibrosis Status: Withdrawn Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20072
20111
20121
20141
20151
20181
20191
20211
20223
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Colorado, Denver2
Actelion1
AmMax Bio, Inc.1
Biosplice Therapeutics, Inc.1
Blade Therapeutics1
Dr. Christopher Lambers1
Hoffmann-La Roche1
Imperial College London1
Modern Biosciences Ltd1
NYU Langone Health1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Idiopathic Pulmonary Fibrosis16
Pulmonary Arterial Hypertension2
Alveolitis, Extrinsic Allergic1
Anemia, Sickle Cell1
Cystic Fibrosis1
Hemophilia A1
Hemophilia B1
Hypertension, Pulmonary1
Lung Diseases, Interstitial1
Myasthenia Gravis1

Trials

Showing 76 to 16 of 16. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.